BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Biotechnology Magazine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Biotechnology Magazine
X-ORIGINAL-URL:https://european-biotechnology.com
X-WR-CALDESC:Events for European Biotechnology Magazine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260721
DTEND;VALUE=DATE:20260724
DTSTAMP:20260619T021342
CREATED:20260604T072421Z
LAST-MODIFIED:20260604T072421Z
UID:20616-1784592000-1784851199@european-biotechnology.com
SUMMARY:Join the only Neoantigen-Specific Summit this July
DESCRIPTION:The 9th International Neoantigen Summit returns to Amsterdam over 21st-23rd July to bring together the only dedicated forum for end-to-end neoantigen development. From validation and identification to clinical readouts\, biomarker strategy\, personalised and off-the-shelf approaches – this is your only platform dedicated to sharing critical developments in neoantigen therapies. \nThis highly focused conference unites all the key players in the neoantigen field from Europe and US across biotech and pharma organisations. It brings together a seniority of 30%+ C-suite alongside directors\, heads and scientists focused on cancer immunotherapy\, clinical & preclinical development\, antigen discovery and validation\, bioinformatics and regulatory considerations. All of them share the goal of developing neoantigen‑targeted therapies – making this conference a must‑attend. \nIn a unique position to unite all the key players in the neoantigen industry\, this summit sits at the heart of the neoantigen industry\, making every conversation relevant and every connection intentional. \nOver 3 jam-packed days of content\, you can expect to: \n\nGain the latest clinical data updates from companies like: Transgene\, CellVax Therapeutics\, Geneos Therapeutics and more\nMaximise bioinformatics and AI to improve neoantigen validation with companies like Evaxion and Khosen Bio\nHear from 6 brand-new speaking companies including Black Canyon Bio\, CellVax Therapeutics\, Echo Immune\, Epitopea\, Khosen Bio\, and Treos Bio\nAnalyse preclinical data to better move through the clinic\n\n…and much more! This conference is your one-stop-shop for all things neoantigen therapy. \nContact info:  \nEmail: info@hansonwade.com \nPhone: \nUK: +44 (0)20 3141 8700\nUS: +1 617 455 4188
URL:https://european-biotechnology.com/highlight/join-the-only-neoantigen-specific-summit-this-july/
LOCATION:Park Plaza Amsterdam Victoria\, Damrak 1-5\, Amsterdam\, 1012 LG\, Netherlands
CATEGORIES:highlight
ATTACH;FMTTYPE=image/png:https://european-biotechnology.com/wp-content/uploads/2026/06/European-Biotech-Magazine-960x540px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261002
DTSTAMP:20260619T021342
CREATED:20260616T115914Z
LAST-MODIFIED:20260616T115914Z
UID:20767-1790640000-1790899199@european-biotechnology.com
SUMMARY:BIOSPAIN 2026
DESCRIPTION:BIOSPAIN 2026 will take place from 29 September to 1 October at the Bilbao Exhibition Centre (BEC)\, bringing together the global biotechnology community under the claim “Bioinnovation that clicks.” Organized by AseBio in collaboration with the Provincial Council of Bizkaia\, the Basque Government and the Basque Health Cluster\, the event reinforces its role as Spain’s flagship biotech congress and one of Europe’s leading life sciences gatherings. \nFor the first time in its history\, BIOSPAIN becomes an annual event\, reflecting the sector’s growing momentum and international demand. The 2025 edition in Barcelona welcomed more than 2\,400 attendees from 35 countries\, confirming BIOSPAIN as a premier platform for business development\, investment and strategic networking. \nHosted for the third time in the Basque Country\, BIOSPAIN 2026 will showcase one of Europe’s most dynamic life sciences ecosystems\, home to more than 300 companies\, 20 research centers\, four universities and world-class hospitals. \nThe programme will address key scientific\, industrial and regulatory trends shaping biotechnology\, including advanced therapies\, AI-driven drug development\, CRISPR\, RNA technologies\, foodtech\, sustainable bioeconomy\, biomanufacturing and European biotech policy. \nWith partnering opportunities\, international investors\, exhibition space and a dedicated Talent Day\, BIOSPAIN 2026 will offer a unique platform to connect innovation\, business and talent.
URL:https://european-biotechnology.com/highlight/biospain-2026/
LOCATION:Bilbao
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/06/BIOSPAIN_Barcelona_2025-scaled-e1781611090578.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20260619T021342
CREATED:20260526T131604Z
LAST-MODIFIED:20260616T120343Z
UID:20450-1791849600-1792022399@european-biotechnology.com
SUMMARY:BIOTECH SUMMIT AUSTRIA 2026
DESCRIPTION:The BIOTECH SUMMIT AUSTRIA returns on October 13–14\, 2026\, bringing Austria’s and Europe’s biotech community together in Innsbruck. As one of the country’s key platforms for biotechnology\, the summit connects leading voices from science\, industry\, startups\, investment\, policy and the wider life science ecosystem – creating a space where ideas\, expertise and partnerships can grow. \nAt the heart of the conference is a central question for the biotech sector: How can excellent science be translated into successful applications\, strong companies and sustainable value creation? Austria has a dynamic and highly innovative biotech landscape\, with outstanding academic research\, ambitious startups\, experienced industry players and a growing network of investors\, experts and support organizations. The BIOTECH SUMMIT AUSTRIA makes this potential visible and brings together the people who can help turn it into real impact. \nThe program offers a carefully curated mix of keynotes\, panel discussions\, workshops\, startup and expert formats\, as well as numerous opportunities for personal B2B meetings. Topics will range from translational research\, financing and scaling to international markets\, collaboration models and the conditions needed to strengthen Austria’s biotech ecosystem. \nA particular strength of the summit is its focus on meaningful personal exchange. Structured 1:1 meetings\, networking sessions and informal encounters provide the ideal setting to meet potential partners\, explore new opportunities and deepen existing relationships. Whether participants are looking for investment\, scientific collaboration\, business development opportunities or fresh perspectives from across the sector\, the summit offers a highly relevant platform for connection and dialogue. \nThe BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA\, Human.technology Styria and Health Hub Tirol / Standortagentur Tirol. The conference language is English. \nContact\, more information & registration:\nwww.biotech-summit-austria.com\nsummit@biotechaustria.org
URL:https://european-biotechnology.com/highlight/biotech-summit-austria-2026/
LOCATION:Innsbruck
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/05/BSA26-Event-Highlight-960x540-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261109
DTEND;VALUE=DATE:20261112
DTSTAMP:20260619T021342
CREATED:20260604T133938Z
LAST-MODIFIED:20260604T133938Z
UID:20630-1794182400-1794441599@european-biotechnology.com
SUMMARY:BIO-Europe 2026
DESCRIPTION:BIO-Europe 2026 strengthens life science leadership\, champions innovation\, and fosters the global partnerships that drive our industry forward. As the landscape evolves\, we’re expanding to meet the needs of the entire biotech ecosystem. \nThe vision for BIO-Europe 2026 convenes the entire biotech pharma C-suite. Six parallel content tracks expand on partnering and investment and therapeutic area topics to include regulatory developments\, clinical affairs\, and manufacturing strategy. Daily plenary sessions address macro-level industry and policy trends impacting global life science leadership\, and new access options support different levels of delegate engagement. \nAt the heart of this vision is our unwavering commitment to global collaboration. BIO-Europe 2026 stands for open dialogue\, building partnerships\, and advancing R&D that improves patient outcomes worldwide. \nTo support the new content tracks\, a new Content-Only registration is available. This non-partnering pass brings BIO-Europe to your whole C-suite. Content-Only attendees will have access to the exhibit hall\, all program tracks\, and the Monday evening event\, while All-Access attendees enjoy the full partnering experience. \nEvent website:\ninformaconnect.com/bioeurope/ \nEmail:\ncssupport1@informa.com \n  \n 
URL:https://european-biotechnology.com/highlight/bio-europe-2026/
LOCATION:Cologne
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/06/eb.com_BIO-Europe-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261126
DTSTAMP:20260619T021342
CREATED:20260213T130059Z
LAST-MODIFIED:20260604T073701Z
UID:19338-1795392000-1795651199@european-biotechnology.com
SUMMARY:PharmaLab Congress and Exhibition 2026 at a new venue
DESCRIPTION:Named after the chemical element Darmstadtium (Ds110)\, it combines the 1\,302 m² spectrum congress hall for exhibition stands with 3\,700 m² of light-flooded foyer space\, giving exhibitors an ideal setting to connect with PharmaLab Congress delegates and exhibition visitors. \nIn 2026\, a new topic will be addressed in a dedicated track: \n– Data Quality Management of Aberrant Results – Handling Out of Specification\, OOS\, and Out of Trend\, OOT results (Pre-Conference\, 23 November ) \nThe established topics will also be covered at PharmaLab 2026 from 23-25 November in Darmstadt – providing participants with the opportunity to exchange knowledge and experiences with representatives from authorities\, industrial experts and scientists from laboratories: \n\nAnalytical Procedure Lifecycle Management (APLM)\nGMP Compliance Trends Analytical Laboratories\nLaboratory Optimization\, Automation and Digitalization/Outsourcing in Pharmaceutical Laboratories\nEndotoxin and Pyrogen Testing\nAlternative and Rapid Microbiological Methods\nCell and Gene Therapies/ ATMPs – Quality and Safety\nBioassays/Potency Assays – Regulatory Requirements\, Developments and Routine Use\nBioanalytical Control of Biological Drug Substances and Products\nQuality Control of mRNA/LNP Products (Pre-Conference\, 23 November)\n7th International Mycoplasma qPCR Testing User Day (Pre-Conference\, 23 November)\n\n\nCongress delegates benefit from 9 parallel conferences\, 3 pre-conference workshops with altogether over 100 presentations\, over 60 exhibitors in the exhibition and the networking event. An update in all relevant areas of pharmaceutical lab developments will be provided. We are also open for poster submissions for the exhibition. \nOne-day and multi-day tickets offer participants the opportunity to attend parts or even the entire congress and thereby put together an individual programme with the lectures of choice. \nWe look forward to welcoming you in Darmstadt at PharmaLab. \nMore information \nWebsite: https://www.pharmalab-congress.com\neMail: info@concept-heidelberg.de
URL:https://european-biotechnology.com/highlight/pharmalab-2026-congress-exhibition/
LOCATION:Darmstadt
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/02/PharmaLab2026_ebm-transkript-event-highlight.jpg
END:VEVENT
END:VCALENDAR